Paget Disease of Bone
📧 Sign up to get email alerts when something new happens for Paget Disease of Bone.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-12-23FDA Approved: FOSAMAX — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Fosamax (alendronate sodium) submitted by Organon LLC.
-
FDA approval · 2013-09-23FDA Approved: ZOLEDRONIC ACID — Original Application (Sagent Pharmaceuticals)
FDA approves a generic zoledronic acid injection from Sagent Pharmaceuticals under ANDA 202828, granting approval to market the product for …
-
FDA approval · 2013-07-15FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for alendronate sodium, manufactured by Amneal Pharmaceuticals of New York LLC. This action appr…
-
FDA approval · 2013-06-03FDA Approved: ZOLEDRONIC ACID — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc.'s original application for a generic zoledronic acid injectable product.
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Inheritance of Osteosarcoma & Paget's Disease Through Chromosome 18:
The clinical trial update notes that the study investigating inheritance of osteosarcoma and Paget disease of bone through chromosome 18 has…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-04-19FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)
FDA approved Allergan's supplemental application for Actonel (risendronate sodium).
-
FDA approval · 2013-04-19FDA Approved: BINOSTO — Supplemental Application (Radius Health, Inc.)
The FDA has approved a supplemental application for BINOSTO (alendronate sodium) from Radius Health, Inc. The approval updates the labeling …
-
FDA approval · 2013-03-29FDA Approved: ALENDRONATE — Supplemental Application (Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for alendronate sodium tablets from Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
-
FDA approval · 2013-03-29FDA Approved: ZOLEDRONIC ACID — Original Application (Dr.Reddy's Laboratories Ltd)
FDA approved the original application for Zoledronic acid (generic) from Dr. Reddy's Laboratories Ltd. This approval confirms a generic vers…
-
FDA approval · 2013-03-04FDA Approved: ZOLEDRONIC ACID — Original Application (Mylan Institutional LLC)
FDA approved an original application for a zoledronic acid generic product manufactured by Mylan Institutional LLC.
-
FDA approval · 2013-02-25FDA Approved: ALENDRONATE SODIUM — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s generic alendronate sodium tablets under an original ANDA (ANDA 090520). The approval covers o…
-
FDA approval · 2013-02-19FDA Approved: MIACALCIN — Supplemental Application (Mylan Institutional LLC)
The FDA approved a supplemental application for Miacalcin (calcitonin salmon) submitted by Mylan Institutional LLC. The action pertains to a…
-
FDA approval · 2013-02-05FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic alendronate sodium product from Aurobindo Pharma Limited (ANDA 090124). The approval a…
-
FDA approval · 2012-07-12FDA Approved: CALCITONIN SALMON — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for Calcitonin Salmon from Endo USA, Inc.
-
FDA approval · 2012-06-25FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for alendronate sodium supplied by Aurobindo Pharma Limited under ANDA090124.
-
FDA approval · 2012-05-22FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for alendronate sodium from Amneal Pharmaceuticals of New York LLC, indicating updated labeling or a…
-
FDA label_change · 2012-05-17FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for alendronate sodium by Aurobindo Pharma Limited, indicating a modification to an already approved…
-
FDA approval · 2012-05-16FDA Approved: ALENDRONATE — Supplemental Application (Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for ALENDRONATE SODIUM tablets from Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd., enabling a …
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period [Phase 3]
This Phase 3 safety and efficacy trial of zoledronic acid for Paget's disease of bone has completed, including an extended observation perio…
-
CLINICAL_TRIALS trial_result · 2012-05-02Clinical Trial Update: Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period [Phase 3]
A Phase 3 safety and efficacy trial of zoledronic acid for Paget's disease of bone completed, with results posted in 2012 after an extended …
-
FDA approval · 2012-04-25FDA Approved: CALCITONIN SALMON — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application for Calcitonin Salmon from Apotex Corp., updating the approved product's regulatory status.
-
FDA approval · 2012-02-06FDA Approved: FOSAMAX — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Fosamax (alendronate sodium) from Organon LLC, updating the drug's labeling and/or approved …
-
FDA approval · 2011-08-31FDA Approved: RECLAST — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for RECLAST (zoledronic acid) submitted by Sandoz Inc.
-
FDA approval · 2011-08-22FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Actonel (risedronate sodium) by Allergan, Inc.
-
FDA approval · 2011-07-07FDA Approved: ALENDRONATE SODIUM — Supplemental Application (EXELAN PHARMACEUTICALS INC.)
FDA approved a supplemental application for alendronate sodium submitted by Exelan Pharmaceuticals.